TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)
$15.63
+$0.21(+1.36%)
45
Overall
60
Value
18
Tech
57
Quality
Market Cap
$49.29B
Volume
2.44M
52W Range
$12.99 - $18.90
Target Price
$20.80
Company Overview
| Mkt Cap | $49.29B | Price | $15.63 |
| Volume | 2.44M | Change | +1.36% |
| P/E Ratio | 0.5 | Open | $15.77 |
| Revenue | $4.6T | Prev Close | $15.42 |
| Net Income | $107.9B | 52W Range | $12.99 - $18.90 |
| Div Yield | 0.64% | Target | $20.80 |
| Overall | 45 | Value | 60 |
| Quality | 57 | Technical | 18 |
No chart data available
Latest News
Takeda’s New Polish Study Tracks Real-World Impact of Fruquintinib in Advanced Colorectal Cancer
TipRanks Clinical-Trials-Auto-Generated Newsdesk•2 days ago
Takeda’s TAK-360 Narcolepsy Trial Moves Forward, Expanding Its Specialty CNS Pipeline
TipRanks Clinical-Trials-Auto-Generated Newsdesk•11 days ago
Takeda’s TAK-360 Narcolepsy Trial Moves Forward, Expanding Its Specialty CNS Pipeline
TipRanks Clinical-Trials-Auto-Generated Newsdesk•11 days ago
STAK Inc. Moves Into AI Data Center Power With Planned U.S. Subsidiary
TipRanks Auto-Generated Newsdesk•11 days ago
Catheter Precision Makes Strategic Investment in Volato Group
TipRanks Auto-Generated Newsdesk•12 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TAK | $15.63 | +1.4% | 2.44M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of) Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW